IDA shorts retreat as Barclays lifts target to $163
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
IDACORP sits well below the crowded end of the regulated utility pack. Short interest at 8.6% of free float compares with higher conviction shorts among mid-size peers; closest correlate LNT has moved 5.1% over the past week, EVRG 2.3%. IDACORP itself is up 4.8% over seven days, the strongest move in its peer group.
Shorts pare back sharply
Short interest fell 21.6% over the past week to 8.6% of free float, pulling back from the October highs when shares outstanding on loan reached roughly 6.6 million. The retreat started around October 23, when positions dropped by more than a million shares in a single session. Over the past month the position is down roughly 10%.
The borrow market tells a different story from the positioning. The cost to borrow jumped 84% over the past week to 0.92%. Yet availability sits at 355%, meaning roughly three-and-a-half shares remain available for every one already borrowed. That is a loose lending pool. The cost move looks like repricing rather than a genuine supply squeeze.
Barclays reverses its own October cut
Barclays analyst Michael Lonegan raised his price target to $163 today, up from $149. That reverses the cut he made on October 9, when he lowered the target from $162 to $149. Morgan Stanley's David Arcaro also lifted his target last month, to $144 from $143. Both firms maintain Overweight. The consensus mean target stands at $154, against a current price of $147.
The October 29 earnings print helped. The stock moved 4% on the day.
Record grid output in September
US Environmental Protection Agency power generation data show IDACORP's gross capacity factor hit 69.97% in September, the largest monthly reading on record since 2024. The figure covers Idaho Power's generation fleet. Retail attention on the stock is also running above its own recent baseline, with a z-score of 2.0 against the prior 90 days as of late October.
What to watch: The $163 Barclays target implies roughly 11% upside from current levels. The level that changes the short picture is a further borrow cost move above 1%, which would begin to signal genuine tightening in a pool that for now remains well supplied.
Stocks in this article
See the live data behind this article on ORTEX.
Open IDA on ORTEX →How this article was generated
- Generated
- 3 Nov 2026, 16:08
- Data as of
- 3 Nov 2026, 15:55
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.